Stifel analysts adjusted their outlook on CRISPR Therapeutics (NASDAQ:CRSP), currently trading at $43.09 with a market capitalization of $3.7 billion, reducing the price target to $49 from the ...

Stifel analysts updated their outlook on HubSpot Inc (NYSE: NYSE:HUBS), raising the stock's price target from the previous $880.00 to a new figure of $925.00. The firm continues to endorse the stock ...

We recently compiled a list of the 10 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...

In a report released today, Brian Butler from Stifel Nicolaus maintained a Buy rating on Casella Waste (CWST – Research Report), with a price ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Onsemi (NASDAQ:ON – Get Free Report) had its price objective reduced by research analysts at Stifel Nicolaus from $60.00 to $52.00 in a research note issued on Tuesday,Benzinga reports. The firm ...

SPS Commerce (NASDAQ:SPSC – Get Free Report) had its price target decreased by analysts at Stifel Nicolaus from $225.00 to $200.00 in a report released on Tuesday,Benzinga reports. The brokerage ...

MoneyLion operates a “content-as-a-service platform” called mFeed, and Stifel Discover is expected to deliver personalized ...

Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...

We recently compiled a list of the 10 AI News Updates on Wall Street’s Radar. In this article, we are going to take a look at ...

According to Benzinga Pro, Stifel Financial's peer group average for short interest as a percentage of float is 3.37%, which ...

Today’s Forbes Daily covers El Segundo’s defense tech movement, Trump’s funding violation, Eric Adams update, Elon Musk’s bid to buy OpenAI, Super Bowl ratings and more.